Published Sep 21, 2026
60 Degrees Pharmaceuticals (SXTP): Babesiosis Option Meets Exhausted Cash Runway
In-depth research on SXTP covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
3,752 words17 min read
Read report